Following the passage of the US Farm Bill final year, new avenues have opened for each industrial hemp grow operations as nicely as improvement of extra hemp-primarily based solutions and cultivation strategies. Taking benefit of these loosened restrictions, Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) now announced a partnership with the University of Connecticut for hemp development investigation.
Researchers from the university’s Department of Plant Science and Landscape Architecture will acquire funding through Curaleaf to create sophisticated cultivation processes towards escalating present production levels.
Led by Dr. Jessica Lubell and Dr. Mark Brand, the outcomes of this partnership’s investigation are anticipated to be officially released inside the subsequent year and will potentially be utilized by Curaleaf towards hemp and health-related cannabis development.
Discussing the impending tissue culture and seed breeding study initiatives, Dr. Lubell commented:
We are really excited to expand our investigation efforts on industrial hemp with funding assistance from Curaleaf. Curaleaf-funded investigation at UConn will not only bring advancements to our understanding of industrial hemp culture and genetics, but it will also train graduate students in this emerging crop.
Dr. Lubell and Dr. Brand have previously authored a series of papers with each other on subjects such as hemp development and building native plant species more than importing invasive plants for decorative purposes. Acquiring her PhD from the University of Connecticut in 2008, Dr. Lubell at the moment serves as an associate professor at the institution.
This Curaleaf-funded project follows a flurry of investigation partnerships announced in current months with institutes of larger studying as nicely as far more unexpected organizations. Final week, Canadian licensed producer Aurora Cannabis (NYSE: ACB TSX: ACB) inked a deal with mixed martial arts promotion enterprise UFC to study the use of hemp-primarily based CBD solutions for athletes in recovery.
On the marijuana side of the market, which remains prohibited at the federal level in the US in spite of becoming legalized in 10 states, a Manhattan investor just pumped $9 million into Harvard University towards researching the effects of cannabis on the human brain.
In other recent Curaleaf news, earlier this month the enterprise announced a $948 million deal to obtain the cannabis item lines and manufacturing processes from Portland-primarily based enterprise Choose.